Translating trials into practice – Clinical implications .

28 August 2017 (13:05 - 13:20)

Organised by:

About the speaker

Professor Marc Pfeffer

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

3 More presentations in this session

Presentation thumbnail

Introduction - GLP-1 receptor agonists and CV risk management in type 2 diabetes: a new treatment paradigm?

Professor L. Ryden (Stockholm, SE)

Presentation thumbnail

Results from the LEADER cardiovascular outcomes trial.

Doctor M. Husain (Toronto, CA)

Presentation thumbnail

Interactive discussions - GLP-1 receptor agonists and CV risk management in type 2 diabetes: a new treatment paradigm?

Professor L. Ryden (Stockholm, SE) Professor M. Pfeffer (Boston, US) Doctor M. Husain (Toronto, CA)

Access the full session

Session thumbnail

GLP-1 receptor agonists and cardiovascular risk management in type 2 diabetes: a new treatment paradigm?

The Event

ESC Congress 2017

28 August 2017 13:05 CET

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources